(603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 603102 · · 17 pages · Chinese
Summary by 6ix AI
The report confirms the accuracy and completeness of the financial information provided, with the board and management taking legal responsibility for its content. Key financial data includes revenue and net profit figures, which show a decline compared to the same period last year. The report also outlines the company's total assets and shareholder equity as of the reporting date.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Weihai Baihe Biology Technological Co., Ltd. on 6ix
Earlier from Weihai Baihe Biology Technological
- (603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors
- (603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Initial Grant of Restricted Shares to Participants under the 2026 Restricted Share Incentive Plan
- (603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Adjustment of Matters Related to the Company's 2026 Restricted Share Incentive Plan
- (603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Self-inspection Report on Trading in the Company's Shares by Insiders in Relation to the 2026 Restricted Share Incentive Plan
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
Follow Weihai Baihe Biology Technological into a list and get an email when it puts out news.
Follow Weihai Baihe Biology Technological